Preview of CLOROX|DE Earnings: Insider Trading, Hedge Fund Activity, and More

CLOROX|DE (CLX) is gearing up to announce its latest quarterly earnings data on Monday, November 3rd, following the close of the market, according to insights from Finnhub. Analysts are anticipating revenue to reach $1,413,839,581 with earnings per share projected at $0.79. If you are keen on staying updated on the latest developments, you can refer to Quiver Quantitative’s detailed CLX stock page, offering comprehensive data on insider trading, hedge fund activities, and even congressional trading.

Taking a closer look at CLOROX|DE, recent insider trading activities shed light on $CLX transactions within the past six months. Notably, there have been two instances of insider trading, comprising one purchase and one sale. Notable transactions within this period include Chief Operating Officer Eric H Reynolds offloading 15,041 shares for an estimated value of $1,861,847, while Pierre R Breber, another top executive, acquired 4,000 shares amounting to around $546,285. For a more detailed overview of insider activities, feel free to browse through Quiver Quantitative’s insider trading dashboard.

Moreover, delving into hedge fund activities related to CLOROX|DE unveils interesting insights. A whopping 514 institutional investors have opted to increase their stakes in CLX stock, while 575 have downsized their positions in the latest quarter. Notable movements include Invesco Ltd. bolstering their portfolio by adding 1,883,465 shares, a substantial spike of 138.3%, valued at approximately $226,147,642. Additionally, Qube Research & Technologies Ltd. augmented their holdings by 1,684,594 shares, a significant surge of 250.2%, worth around $202,269,201. On the flip side, BlackRock, Inc. chose to reduce its shares by 1,342,815 units, a decline of 11.3%, with an approximate value of $161,231,797. For in-depth insights into hedge funds’ stock portfolios, head over to Quiver Quantitative’s institutional holdings dashboard.

Moving on to congressional stock trading involving CLOROX|DE, there has been one notable transaction among members of Congress in the past six months. A single purchase was made, with Representative Lisa C. McClain acquiring up to $15,000 worth of CLX stock on 06/24. To monitor congressional stock trading activities closely, make sure to explore Quiver Quantitative’s congressional trading dashboard.

Lastly, analysts have been actively weighing in on CLOROX|DE, issuing a mix of buy and sell ratings over the recent months. Notable mentions include Barclays issuing an “Underweight” rating on 10/01/2025, alongside Jefferies presenting a “Buy” rating on 06/26/2025. To stay informed on analyst ratings and price targets concerning CLOROX|DE, navigate to Quiver Quantitative’s CLX forecast page to access detailed insights.